Artelo Biosciences Liabilities 2024

Artelo Biosciences Aktienanalyse

What does Artelo Biosciences do?

Artelo Biosciences Inc is an innovative biopharmaceutical company specializing in the research and development of new therapies for the treatment of cancer and inflammatory diseases. The company was founded in 2011 and is headquartered in Manchester, UK, with a branch office in San Diego, USA. Artelo Biosciences Inc began with the discovery of new drug candidates based on the body's endocannabinoid system, which plays a crucial role in regulating various physiological processes such as pain, inflammation, mood, and appetite. The company's business model is based on identifying and researching new drug candidates based on the endocannabinoid system, as well as developing and marketing new therapies for the treatment of cancer and inflammatory diseases. Artelo Biosciences Inc operates in various sectors, including cancer therapy, inflammation inhibition, and neurological disorders. In cancer therapy, the company focuses on the development of new drugs for the treatment of solid tumors, particularly triple-negative breast cancer (TNBC), a highly aggressive type of cancer for which there are currently limited therapy options. Artelo Biosciences Inc has several promising drug candidates, including ART27.13, a synthetic cannabinoid receptor agonist that has shown in preclinical studies to inhibit the growth of TNBC cells. In inflammation inhibition, Artelo Biosciences Inc focuses on the development of new drugs for the treatment of diabetes, obesity, and inflammatory bowel diseases. The company has several promising drug candidates, including ART26.12, a synthetic endocannabinoid receptor agonist that has shown in preclinical studies to reduce inflammation in the intestine and improve insulin sensitivity. In neurological therapy, Artelo Biosciences Inc focuses on the development of new drugs for the treatment of anxiety and pain. The company has several promising drug candidates, including ART12.11, a synthetic endocannabinoid receptor agonist that has shown in preclinical studies to reduce anxiety and inhibit pain perception. Artelo Biosciences Inc closely collaborates with leading academic institutions and research centers to develop and test its drug candidates. The company has a strong research and development department composed of highly qualified scientists and clinicians. It also has an effective licensing and marketing strategy to bring its products to market. In summary, Artelo Biosciences Inc is an innovative biopharmaceutical company specializing in the research and development of new therapies for the treatment of cancer and inflammatory diseases. The company's business model is based on identifying and researching new drug candidates based on the endocannabinoid system, as well as developing and marketing new therapies. The company operates in various sectors, including cancer therapy, inflammation inhibition, and neurological disorders. Artelo Biosciences Inc has its own patents and licenses, a strong research and development department, and an effective licensing and marketing strategy to bring its products to market. Artelo Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Artelo Biosciences's Liabilities

Artelo Biosciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Artelo Biosciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Artelo Biosciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Artelo Biosciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Artelo Biosciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Artelo Biosciences Stock

What is the level of liabilities of Artelo Biosciences this year?

Artelo Biosciences has a debt balance of 1.29 M USD this year.

What were the liabilities of Artelo Biosciences compared to the previous year?

The liabilities of Artelo Biosciences have increased by 26.57% increased compared to the previous year.

What are the consequences of high debt for investors of Artelo Biosciences?

High liabilities can pose a risk for investors of Artelo Biosciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Artelo Biosciences?

Low liabilities mean that Artelo Biosciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Artelo Biosciences affect the company?

An increase in liabilities of Artelo Biosciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Artelo Biosciences affect the company?

A decrease in the liabilities of Artelo Biosciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Artelo Biosciences?

Some factors that can influence the liabilities of Artelo Biosciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Artelo Biosciences so important for investors?

The liabilities of Artelo Biosciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Artelo Biosciences take to modify the liabilities?

To change its liabilities, Artelo Biosciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Artelo Biosciences pay?

Over the past 12 months, Artelo Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Artelo Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Artelo Biosciences?

The current dividend yield of Artelo Biosciences is .

When does Artelo Biosciences pay dividends?

Artelo Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Artelo Biosciences?

Artelo Biosciences paid dividends every year for the past 0 years.

What is the dividend of Artelo Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Artelo Biosciences located?

Artelo Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Artelo Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Artelo Biosciences from 6/23/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/23/2024.

When did Artelo Biosciences pay the last dividend?

The last dividend was paid out on 6/23/2024.

What was the dividend of Artelo Biosciences in the year 2023?

In the year 2023, Artelo Biosciences distributed 0 USD as dividends.

In which currency does Artelo Biosciences pay out the dividend?

The dividends of Artelo Biosciences are distributed in USD.